Leveraging a disulfidptosis‑related lncRNAs signature for predicting the prognosis and immunotherapy of glioma

Leveraging a disulfidptosis‑related lncRNAs signature for predicting the prognosis and immunotherapy of glioma

Abstract Background Gliomas, a prevalent form of primary brain tumors, are linked with a high mortality rate and unfavorable prognoses. Disulfidptosis, an innovative form of programmed cell death, has received scant attention concerning disulfidptosis-related lncRNAs (DRLs). The objective of this in...

Full description

Bibliographic Details
Main Authors: Di Chen, Qiaoqiao Li, Yuan Xu, Yanfei Wei, Jianguo Li, Xuqiang Zhu, Hongjiang Li, Yan Lu, Xianzhi Liu, Dongming Yan
Format: Article
Language:English
Published: BMC 2023-12-01
Series:Cancer Cell International
Subjects:
Disulfidptosis
Long noncoding RNA
Prognostic signature
Glioma
Immune microenvironment
Drug sensitivity
Online Access:https://doi.org/10.1186/s12935-023-03147-7

Internet

https://doi.org/10.1186/s12935-023-03147-7

Similar Items